These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9772758)

  • 21. A protocol to evaluate drug-related workplace impairment.
    Reisfield GM; Shults T; Demery J; Dupont R
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):43-8. PubMed ID: 23527668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical substance abuse in radiology.
    Lam RW
    Adm Radiol J; 1998 Apr; 17(4):13-6. PubMed ID: 10181524
    [No Abstract]   [Full Text] [Related]  

  • 23. A new challenge for drug-free workplace programs.
    DuPont RL; Martin DM; Skipper GE
    Occup Health Saf; 2012 Feb; 81(2):32, 34. PubMed ID: 22435238
    [No Abstract]   [Full Text] [Related]  

  • 24. Drugs and the workplace.
    World Health Forum; 1991; 12(4):495-6. PubMed ID: 1821126
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug testing as part of the war on drugs.
    Gerson B; Subramaniam S
    Clin Lab Med; 1998 Dec; 18(4):781-803, xi. PubMed ID: 9891615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Special report. Drug usage by employees: an update.
    Hosp Secur Saf Manage; 1992 Jun; 13(2):5-9. PubMed ID: 10171055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs in the workplace: research and evaluation data.
    NIDA Res Monogr; 1990; 100():3-238. PubMed ID: 2132775
    [No Abstract]   [Full Text] [Related]  

  • 28. Health promotion in the work-place--beyond an ethnocentric perspective.
    Klingemann HK
    Addiction; 1995 Jul; 90(7):877-81. PubMed ID: 7663310
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug use trends in a nuclear power facility: data from a random screening program.
    Osborn CE; Sokolov JJ
    NIDA Res Monogr; 1990; 100():63-77. PubMed ID: 2132778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing employee drug abuse starts with firm policy, awareness.
    Thieme C
    Occup Health Saf; 1990 Sep; 59(10):41, 48. PubMed ID: 2234742
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug screening & the ADA.
    Watts C
    Occup Health Saf; 2001 Apr; 70(4):80-2. PubMed ID: 11326588
    [No Abstract]   [Full Text] [Related]  

  • 32. [Organizational, legal, and methodical aspects of drug abuse prevention].
    Novikov VA; Dorovskikh IV; Mal'tsev GIu; Likhachev AA; Kozlov AA
    Voen Med Zh; 2007 Apr; 328(4):62-7. PubMed ID: 17580495
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug screening in the workplace: use, abuse and implications.
    Grabowski J; Silverman PB
    NIDA Res Monogr; 1989; 95():225-31. PubMed ID: 2640968
    [No Abstract]   [Full Text] [Related]  

  • 34. Research on drugs and the workplace: introduction and summary.
    Gust SW; Crouch DJ; Walsh JM
    NIDA Res Monogr; 1990; 100():3-8. PubMed ID: 2132776
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug addiction and working].
    Mariotti O
    G Ital Med Lav Ergon; 2004; 26(3):247-50. PubMed ID: 15551955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The synergism of health promotion and restoration in the prevention of substance abuse in the workplace.
    Miller RE; Shain M; Crim D; Golaszewski TJ
    Health Values; 1985; 9(5):50-8. PubMed ID: 10317664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing employees.
    Hadfield L
    Drug Test Anal; 2009 Mar; 1(3):116-7. PubMed ID: 20355183
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug testing in the workplace: integrating medical review officer duties into occupational medicine.
    Smith DE; Glatt W; Tucker DE; Deutsch R; Seymour RB
    Occup Med; 2002; 17(1):79-90, v. PubMed ID: 11726338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers].
    Magnavita N; Bergamaschi A; Chiarotti M; Colombi A; Deidda B; De Lorenzo G; Goggiamani A; Magnavita G; Ricciardi W; Sacco A; Spagnolo AG; Bevilacqua L; Brunati MM; Campanile T; Cappai M; Cicerone M; Ciprani F; Di Giannantonio M; Di Martino G; Fenudi L; Garbarino S; Lopez A; Mammi F; Orsini D; Ranalletta D; Simonazzi S; Stanzani C
    Med Lav; 2008; 99 Suppl 2():3-58. PubMed ID: 19248471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Questionnaire for the evaluation of drug preventive intervention programmes at the workplace (FEBSI)].
    Loeber S; Mann K; Croissant B
    Gesundheitswesen; 2009 Mar; 71(3):134-9. PubMed ID: 19224441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.